drug
riluzole
Marketedupdated 3mo agoby Rising Pharma Holdings Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 2indications
investigational
ALS
all catalysts(0)
nothing on the calendar yet
Trials studying riluzole
- phase3A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
- phase2PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS
- phase1Pharmacokinetics of Y-4 Tablets With Pregabalin Capsules and Riluzole Tablets in U.S. Healthy Participants
- phase3Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder
- phase3Troriluzole (BHV-4157) in Adult Participants With Obsessive Compulsive Disorder
- —Expanded Access Protocol of Troriluzole in Patients With Spinocerebellar Ataxia (SCA)
- phase3Efficacy and Safety Study of Adjunctive Troriluzole in Obsessive Compulsive Disorder
- phase3Troriluzole in Adult Participants With Spinocerebellar Ataxia
Patent cliff
source: FDA Orange Bookfirst barrier falls
Mar 12, 2029
~2.6 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (1)
- Mar 12, 2029formulationUS 87651502.6y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 10m ago
Found something off?
comments(0)
5-min edit window · permanent after that